Skip to main content

UBS Group AG

Position in LKFT — Lakefront Biotherapeutics NV

CIK 1610520 ZURICH, V8

Position in LKFT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,041,077
-$217,593 QoQ
Shares Held
168,148
-4.1% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 78 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LKFT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,271,661 across 562 Biotechnology names. LKFT ranks #147 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LKFT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,041,077 168,148
2026-03-31 $5,258,670 175,289
2025-12-31 $11,426,818 349,444
2025-09-30 $5,299,884 152,999
2025-06-30 $6,676,286 238,524
2025-03-31 $2,738,354 109,011
2024-12-31 $2,078,422 75,579
2024-09-30 $28,270 982
2024-06-30 $26,167 1,056
2024-03-31 $44,339 1,377
2023-12-31 $79,632 1,959
2023-09-30 $23,458 679
2023-06-30 $52,857 1,300
2023-03-31 $29,790 771
2022-12-31 $159,900 3,603
2022-09-30 $64,342 1,509
2022-06-30 $53,120 952
2022-03-31 $49,987 806
2021-12-31 $3,649,715 66,202
2021-09-30 $45,664 868
2021-06-30 $149,146 2,165
2021-03-31 $71,924 933
2020-12-31 $173,214 1,750
2020-09-30 $98,342 693
2020-06-30 $273,246 1,385
2020-03-31 $125,975 643